Mechanisms and clinical implications of glucocorticosteroids in the treatment of allergic rhinitis
- 6 August 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 158 (2), 164-173
- https://doi.org/10.1111/j.1365-2249.2009.04010.x
Abstract
Summary: Allergic rhinitis is a common airway disease characterized by hypersensitivity, exudation, hypersecretion, inflammatory cell infiltration and remodelling. Intranasal glucocorticosteroids are the most effective drugs for controlling the inflammation caused by allergic rhinitis. Glucocorticosteroids exert anti-inflammatory effects through at least two pathways: the transactivation pathway and the transrepression pathway. Glucocorticosteroids also exert regulatory functions by inducing regulatory cytokines and forkhead box P3 (FoxP3+) regulatory T cells. Evidence suggests that intranasal glucocorticosteroids control not only nasal symptoms but also ocular symptoms. In contrast to sedating H1 receptor antagonists, intranasal glucocorticosteroids can improve impaired performance symptoms, such as daytime sleepiness, associated with allergic rhinitis. Recent studies suggest that intranasal glucocorticosteroids might also be useful for the prophylactic treatment of pollinosis; this possibility is supported by the molecular mechanism of the anti-inflammatory action of glucocorticosteroids. These findings suggest that intranasal glucocorticosteroids might be positioned as first-line drugs for the treatment of both perennial and seasonal allergic rhinitis.Keywords
This publication has 97 references indexed in Scilit:
- Acute regulation of tight junction ion selectivity in human airway epitheliaProceedings of the National Academy of Sciences of the United States of America, 2009
- Regulatory T cells in bronchial asthmaAllergy, 2009
- Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*Allergy, 2008
- Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipperBlood, 2007
- Different mechanisms between thromboxane A2- and leukotriene D4-induced nasal blockage in guinea pigsProstaglandins & Other Lipid Mediators, 2006
- HLA-DR- and CD11c-positive Dendritic Cells Penetrate beyond Well-developed Epithelial Tight Junctions in Human Nasal Mucosa of Allergic RhinitisJournal of Histochemistry & Cytochemistry, 2005
- IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapyEuropean Journal of Immunology, 2003
- Intranasal mometasone furoate reduces late-phase inflammation after allergen challengeAnnals of Allergy, Asthma & Immunology, 2001
- Glucocorticosteroids Inhibit Leukotriene ProductionAnnals of Allergy, Asthma & Immunology, 1997
- Oral Methylprednisolone Acetate (Medrol Tablets) for Seasonal Rhinitis: Examination of Dose and Symptom ResponseThe Journal of Clinical Pharmacology, 1993